Clinical Trials Directory

Trials / Completed

CompletedNCT01212718

Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase

Stratified and Randomized Multi-center Phase II - to Determine Potential Benefit of Treating Patients With Advanced Colorectal Cancer According to the Intratumoral TS RNA Levels

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
168 (actual)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study was to evaluate the feasibility of TS determination in a multicenter trial setting using a central facility for measurement and confirm its role as predictive factor for 5-FU treatment in MCRC.

Detailed description

Eligible were patients with non-resectable metastasized or recurrent histologically proven CRC with the presence of a reference lesion two-dimensional measurable and accessible for a biopsy.The biopsy was taken from the reference lesion either by surgery during primary tumor resection, by trans-cutaneous true-cut needle biopsy or by trans-anal approach. Intratumoral relative TS mRNA expression levels were determined using samples shipped in RNA-preserving solution or as glass slides after microdissection of tumor cells. An independent company stratified the patients according to ther relative TS mRNA expression level in TS low and TS high followed by randomization to receive either FUFA of Folfiri. Response to chemotherapy was evaluated and documented according to the RECIST criteria after every therapy cycle.

Conditions

Interventions

TypeNameDescription
DRUGFUFA2600/500 mg/m2 i.v. 24 h via port, 1 time weekly for six weeks, than have a break for 2 weeks (=8 weeks for 1 cycle)
DRUGsystemic chemotherapyCPT-11, 80 mg/m2 for 90 minutes and 5 FU/FA 2000/500 mg/m2 iv. 24h via port; 1 time weekly for six weeks, than have a break for 2 weeks

Timeline

Start date
2001-07-01
Primary completion
2010-06-01
Completion
2010-09-01
First posted
2010-10-01
Last updated
2010-10-01

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01212718. Inclusion in this directory is not an endorsement.